Lataa...
Association of tamoxifen resistance and lipid reprogramming in breast cancer
BACKGROUND: Tamoxifen treatment of estrogen receptor (ER)-positive breast cancer reduces mortality by 31%. However, over half of advanced ER-positive breast cancers are intrinsically resistant to tamoxifen and about 40% will acquire the resistance during the treatment. METHODS: In order to explore m...
Tallennettuna:
| Julkaisussa: | BMC Cancer |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6109356/ https://ncbi.nlm.nih.gov/pubmed/30143015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4757-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|